MassChallenge Startups Create Impact


Startups Accelerated


Funding Raised


Revenue Generated


Jobs Created

Our startups

Be inspired. Search our startups.

Oxalo Therapeutics, Inc.
Oxalo Therapeutics, Inc.

Oxalo Therapeutics is developing a novel drug to prevent recurrent kidney stones. Spun out from the University of Chicago, we use breakthrough discoveries from microbiome research to finally address an underlying cause of kidney stones. Every year kidney stones cause 1.3M+ ER visits and $10+ billion of healthcare costs. Most dangerously, they have a recurrence rate of ~70%. By focusing on prevention, we can end the debilitating pain and tremendous economic burden of this chronic disease.
Biotech company developing a first-in-class drug to treat and prevent kidney stones using breakthroughs in microbiome research.

Connect with Oxalo Therapeutics, Inc.


2018 Platinum Boston

Sub industry

Therapeutics (Pharma / Biotech)


MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.